Jan Swasthya Abhiyan recently announced the recipients of the 4th Amit Sengupta Fellowship on Health Rights. The announcement was followed by reflections on Dr. Sengupta’s activist legacy and a discussion on tuberculosis in India

Un día antes del Día Mundial de la Tuberculosis, la Oficina de Patentes de la India rechazó la solicitud del gigante farmacéutico Jannsen de prorrogar la patente del medicamento bedaquilina.

In today’s episode, we look at a verdict from India that will bring relief to patients of drug-resistant TB, the dismissal of workers from a factory in Myanmar and the ban on transgender athletes from participating in women’s events

Treatment and care for TB patients was sidelined in this period of the pandemic causing the number of deaths from to rise again after many years, and years of progress to be reversed

While India continues its poor performance in the global fight against TB, additional challenges are emerging in the form of Delamanid stock-outs and shortage of testing kits. Despite repeated inquiries from activists, the government keeps mum